Topic: therapeutics and vaccine development

Canada showed strong growth in patents for pandemic prevention technology in last two decades, CIPO report finds

Canada ranked eighth globally in the number of patented pandemic mitigation technologies filed by institutions worldwide between 1999 and 2018, according to a report by the Canadian Intellectual Property Office done in collaboration with the National Research Council. The report found that Canadian institutions had a high relative specialization for pandemic mitigation technologies, especially in the therapeutics and vaccine development research area.

The Short Report – April 28, 2021: COVID-19 data portal goes live, Protein Industries Canada launches new phase of plant-based food plan, Carleton funding bolsters ecosystem conservation, and more

Genome Canada’s portal for tracking variants of concern across Canada is up and running; a Carleton biology team gets support for bolstering ecosystem conservation; Protein Industries Canada starts the second phase of plans to boost plant-based foods, feed and ingredients; a briefing from the Royal Society of Canada calls on federal leadership to stabilize the postsecondary sector; and more.